Methods for treatment of Alzheimer's disease
US8785390B2 · kind B2 · utility
2Cited by
2References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 29, 2010 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Jan 29, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1709
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An isolated protein selected from the group consisting of (i) proteins comprising an amino acid sequence having at least 70% identity to the C-terminal domain of lung surfactant protein C precursor (CTproSP-C, “CTC”) from a mammal; and (ii) proteins comprising an amino acid sequence having at least 70% identity to the Brichos domain of CTproSP-C from a mammal, is disclosed for treatment of Alzheimer's disease in a mammal, including man.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.